ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells-Reference-Cited by-同舟云学术

ABT199/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in acute myeloid leukemia cells

Published:2022-02-10 Issue:1 Volume:13 Page:319-330
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Valdez Benigno C.¹,Murray David²,Yuan Bin¹,Nieto Yago¹,Popat Uday¹,Andersson Borje S.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

2. Division/Department of Experimental Oncology, University of Alberta/Cross Cancer Institute, Edmonton T6G 1Z2, Alberta, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Reference45 articles.

1. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation;Michallet;J Clin Oncol,2013

2. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?;Ferrant;Blood,2007

3. S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine;Plunkett;Cancer Res,2001

4. Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies;Andersson;Environ Mol Mutagen,2010

5. Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity;Plunkett;J Biol Chem,1990

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cells;Oncotarget;2024-03-14

2. Synergistic cytotoxicity of fludarabine, clofarabine, busulfan, vorinostat and olaparib in AML cells;Frontiers in Oncology;2023-11-23

3. Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms;Annals of Hematology;2023-10-25

4. Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML;Annals of Medicine;2023-01-11

5. Chemotherapy;Medicines for Cancer;2023